A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Rutgers, The State University of New Jersey
University Health Network, Toronto
M.D. Anderson Cancer Center
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Karyopharm Therapeutics Inc
Peking Union Medical College Hospital
Universitair Ziekenhuis Brussel